预防性癌症疫苗引起的人类抗MUC1抗体具有多重的效应器功能
Michelle L McKeague1, Jason Lohmueller1,2,3,4, Matthew T Dracz1
1Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Antibodies (Basel, Switzerland)
|October 25, 2024
概括
这项研究评估了用于预防结肠癌的MUC1疫苗. 针对MUC1的单克隆抗体 (mAbs) 在抗体依赖的细胞功能中表现出有效性,在膜定表位上观察到的最佳活性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 素-1 (MUC1) 在前恶性和恶性细胞中过度表达,成为癌症免疫治疗的潜在标.
- 在高风险人群中研究了一种MUC1疫苗,以评估其在预防结肠癌方面的可行性.
研究的目的:
- 评估用于预防结肠癌的MUC1疫苗的可行性.
- 克隆和表征抗MUC1单克隆抗体 (mAbs),以发现它们在瘤排斥中的潜力.
主要方法:
- 患结肠癌高风险的健康人群接受了MUC1疫苗.
- 抗MUC1mAbs是由接种疫苗后的B细胞和血清产生的.
- 测试了三种高结合的mAbs对MUC1+点细胞的效应器功能.
主要成果:
- 所有测试的mAbs均介于抗体依赖性细胞因子释放 (ADCR),细胞毒性 (ADCC) 和细胞化 (ADCP).
- 两个mAbs也表明了抗体依赖的细胞/细胞 (ADCT).
- 没有观察到补充依赖性细胞毒性 (CDC).
结论:
- 抗体依赖细胞功能 (ADCP,ADCT) 在抗体向膜固的MUC1表位时更有效.
- 这些发现为优化针对MUC1.1的治疗抗体策略提供了洞察力.
相关概念视频
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Vaccinations
44.1K
Overview
44.1K
Antigens Involved in Adaptive Immunity
463
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
463
Cross-reactivity
31.0K
Overview
31.0K
Immune Response Against Viral Pathogens
754
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
754
Cell-mediated Immune Responses
67.4K
Overview
67.4K


